This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Amorepacific Corporation. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Yang Hui Park: Innovator in Cannabinoid Research
Introduction
Yang Hui Park is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of cannabinoid research, particularly through his innovative patent that addresses the cannabinoid receptor-1.
Latest Patents
Yang Hui Park holds a patent for a compound acting as a cannabinoid receptor-1 inhibitor. This novel compound is a pyrazolo[1,5-a]pyrimidine derivative, which may include a prodrug, an isomer, a pharmaceutically acceptable salt, a hydrate, or a solvate. The compound is particularly useful for preventing or treating diseases mediated by the cannabinoid receptor-1. He has 1 patent to his name.
Career Highlights
Yang Hui Park is currently employed at Amorepacific Corporation, where he continues to advance his research and development efforts. His work is pivotal in exploring new therapeutic avenues related to cannabinoid receptors.
Collaborations
He collaborates with esteemed colleagues such as Song Seok Shin and Yong Deog Hong, contributing to a dynamic research environment that fosters innovation.
Conclusion
Yang Hui Park's contributions to cannabinoid research exemplify the impact of innovative thinking in the pharmaceutical industry. His work not only enhances our understanding of cannabinoid receptors but also opens new pathways for treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile